Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Receivables (2016 - 2025)

Jaguar Health (JAGX) has disclosed Receivables for 11 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • Quarterly Receivables rose 3.1% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2025, up 3.1% year-over-year, with the annual reading at $1.7 million for FY2025, 3.1% up from the prior year.
  • Receivables for Q4 2025 was $1.7 million at Jaguar Health, up from $1.5 million in the prior quarter.
  • The five-year high for Receivables was $5.9 million in Q1 2021, with the low at $1.3 million in Q3 2024.
  • Average Receivables over 5 years is $2.1 million, with a median of $1.8 million recorded in 2023.
  • The sharpest move saw Receivables soared 445.26% in 2021, then tumbled 61.95% in 2022.
  • Over 5 years, Receivables stood at $2.1 million in 2021, then increased by 15.07% to $2.5 million in 2022, then fell by 11.47% to $2.2 million in 2023, then dropped by 24.59% to $1.6 million in 2024, then rose by 3.1% to $1.7 million in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $1.7 million, $1.5 million, and $1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.